Overview

Donor Simvastatin Treatment in Organ Transplantation

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate the effects of donor simvastatin treatment on ischemia-reperfusion injury after heart transplantation.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Helsinki University Central Hospital
Collaborators:
Academy of Finland
Helsinki University
University of Helsinki
Treatments:
Simvastatin